News and Media

There is a company on the Bulgarian Stock Exchange with a value of over a billion leva, according to data in the bulletin of the stock exchange operator for the second quarter. This is Tchaikapharma High Quality Medicines. By the end of June, the stock exchange players estimated the pharmaceutical company at BGN 1,027,500,000.   […]

Tchaikapharma High Quality Medicines’ shares increased by 1.8% at the end of the trading Monday, March 23, and the closing price reached BGN 11.60. Since the beginning of the year, the company has increased its share price by 6.42%.

In the past year, Tchaikapharma has consolidated its leading position through the successful development of numerous scientific projects, the basis of which is advanced research work on the development and implementation of innovative combined medicinal products (polypills) that have not been applied so far in the world medical practice. A number of successful laboratory studies […]

Distant leader in the treatment of cardiovascular disease among all drug manufacturers present on the Bulgarian market with market share 10.57% in 2017 and 11.39% for the first half of 2018 (Source:  IQVIA/IMS Health), with deep potential for further growth following the market entry of newly developed and introduced medicaments. Tchaikapharma 7TH

The Financial Supervision Commission (FSC) registered the shares issued by Tchaikapharma High Quality Medicines Inc. as a result of an increase of the company’s capital with a view to trading on a regulated securities market. This is evident from the regulator’s decisions at the meeting held on the 23rd of August. The equity issue amounts […]